Virginia Lyle King
Senior Associate at Cure Ventures
About
A researcher with over 10 years of experience in academic and venture contexts. Conducted molecular and cell biology research at the University of Connecticut focusing on cellular stress responses and cancer biology. Combines scientific expertise with deal sourcing, due diligence, and company creation efforts.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures